Media Room
Second quarter 2024 results
Second quarter 2024 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.
Thursday July 25, 2024
14:30 - 16:00 CET (8:30am – 10am EST)
Press releases
September 12, 2024
Press Release: Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers
September 11, 2024
Press Release: Dupixent phase 3 study confirms significant improvements in itch and hives for patients with CSU
September 11, 2024
Press Release: Dupixent is the first and only biologic to achieve significant improvements in disease remission and symptoms in bullous pemphigoid positive pivotal study
Contact Our Media Team
You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.
Publications
Half Year 2024 Financial Report XBRL Package
Half Year 2024 Financial Report
Declaration of extra-financial performance 2023 (ESG Report)
Half Year 2023 Financial Report